Sputnik V is the world’s first registered vaccine based on a well-studied human adenoviral vector-based platform. Sputnik V is one of the three vaccines in the world with efficacy of over 90%. – Read More
The Kremlin spokesman emphasized that respective Russian agencies carry out the toughest control over complying with all requirements for producing COVID-19 vaccines.
Via the Russian Direct Investment Fund, the authorities established a mechanism for using foreign sites, where the substance for the production of vaccines is sent to, the minister said.
An efficacy study was conducted in Bahrain in accordance with WHO guidelines involving more than 5,000 subjects. Overall efficacy beyond 14 days after administering the second dose was estimated at 94.3%.